These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28096700)

  • 1. Sequential Combination Chemotherapy of Dacarbazine (DTIC) with Carboplatin and Paclitaxel for Patients with Metastatic Mucosal Melanoma of Nasal Cavity and Paranasal Sinuses.
    Omata W; Tsutsumida A; Namikawa K; Takahashi A; Oashi K; Yamazaki N
    Clin Med Insights Case Rep; 2017; 10():1-5. PubMed ID: 28096700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoimmunotherapy of advanced malignant melanoma: sequential administration of subcutaneous interleukin-2 and interferon-alpha after intravenous dacarbazine and carboplatin or intravenous dacarbazine, cisplatin, carmustine and tamoxifen.
    Atzpodien J; Lopez Hänninen E; Kirchner H; Franzke A; Körfer A; Volkenandt M; Duensing S; Schomburg A; Chaitchik S; Poliwoda H
    Eur J Cancer; 1995 Jun; 31A(6):876-81. PubMed ID: 7646914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chemo-/immunotherapy in advanced malignant melanoma: carboplatin and DTIC or cisplatin, dtic, bcnu and tamoxifen followed by immunotherapy with interleukin 2 and interferon alpha-2a].
    Kirchner HH; Atzpodien J; Poliwoda H
    Med Klin (Munich); 1996 Apr; 91 Suppl 3():44-9. PubMed ID: 8692119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The epidemiology and clinical characteristics of malignant melanoma localized in nasal cavity and paranasal sinuses--analysis of 6 cases].
    Ziółkowska M; Bień S; Klimas A; Zyłka S
    Otolaryngol Pol; 2008; 62(4):500-3. PubMed ID: 18837235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal melanoma of the nasal cavity and paranasal sinuses.
    Gilain L; Houette A; Montalban A; Mom T; Saroul N
    Eur Ann Otorhinolaryngol Head Neck Dis; 2014 Dec; 131(6):365-369. PubMed ID: 24906226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dacarbazine-based chemotherapy for metastatic melanoma: thirty-year experience overview.
    Serrone L; Zeuli M; Sega FM; Cognetti F
    J Exp Clin Cancer Res; 2000 Mar; 19(1):21-34. PubMed ID: 10840932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-center retrospective series of fourteen patients with mucosal melanoma of the nasal cavity and paranasal sinuses.
    Letievant JC; Poupart M; Ambrun A; Colin C; Pignat JC
    Eur Ann Otorhinolaryngol Head Neck Dis; 2016 Dec; 133(6):387-391. PubMed ID: 27502822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ipilimumab for Previously Untreated Unresectable Malignant Melanoma: A Critique of the Evidence.
    Giannopoulou C; Sideris E; Wade R; Moe-Byrne T; Eastwood A; McKenna C
    Pharmacoeconomics; 2015 Dec; 33(12):1269-79. PubMed ID: 26043718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of paclitaxel/carboplatin salvage chemotherapy in noncutaneous versus cutaneous metastatic melanoma.
    Chang W; Lee SJ; Park S; Choi MK; Hong JY; Kim YS; Maeng CH; Jung HA; Kim S; Lee J
    Melanoma Res; 2013 Apr; 23(2):147-51. PubMed ID: 23411477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting nodal in conjunction with dacarbazine induces synergistic anticancer effects in metastatic melanoma.
    Hardy KM; Strizzi L; Margaryan NV; Gupta K; Murphy GF; Scolyer RA; Hendrix MJ
    Mol Cancer Res; 2015 Apr; 13(4):670-80. PubMed ID: 25767211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vinblastin-carboplatin for metastatic cutaneous melanoma as first-line chemotherapy and in dacarbazine failures: a single-center study.
    Jelić S; Babović N; Stamatović L; Kreacić M; Matković S; Popov I
    Med Oncol; 2001; 18(3):189-95. PubMed ID: 11917943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Docetaxel in combination with dacarbazine in patients with advanced melanoma.
    Bafaloukos D; Aravantinos G; Fountzilas G; Stathopoulos G; Gogas H; Samonis G; Briasoulis E; Mylonakis N; Skarlos DV; Kosmidis P
    Oncology; 2002; 63(4):333-7. PubMed ID: 12417787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin and carboplatin combination as second-line chemotherapy in dacarbazine-resistant melanoma patients.
    Güven K; Kittler H; Wolff K; Pehamberger H
    Melanoma Res; 2001 Aug; 11(4):411-5. PubMed ID: 11479430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large randomized study of thymosin alpha 1, interferon alfa, or both in combination with dacarbazine in patients with metastatic melanoma.
    Maio M; Mackiewicz A; Testori A; Trefzer U; Ferraresi V; Jassem J; Garbe C; Lesimple T; Guillot B; Gascon P; Gilde K; Camerini R; Cognetti F;
    J Clin Oncol; 2010 Apr; 28(10):1780-7. PubMed ID: 20194853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-agent DTIC versus combination chemotherapy with or without immunotherapy in metastatic melanoma: a meta-analysis of 3273 patients from 20 randomized trials.
    Huncharek M; Caubet JF; McGarry R
    Melanoma Res; 2001 Feb; 11(1):75-81. PubMed ID: 11254118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Network Meta-analysis of Progression-Free Survival and Overall Survival in First-Line Treatment of BRAF Mutation-Positive Metastatic Melanoma.
    Amdahl J; Chen L; Delea TE
    Oncol Ther; 2016; 4(2):239-256. PubMed ID: 28261653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose, double alkylating agent chemotherapy with DTIC, melphalan, or ifosfamide and marrow rescue for metastatic malignant melanoma.
    Thatcher D; Lind M; Morgenstern G; Carr T; Chadwick G; Jones R; Craig P
    Cancer; 1989 Apr; 63(7):1296-302. PubMed ID: 2646005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure patterns and prognostic factors of patients with primary mucosal melanoma of the nasal cavity and paranasal sinuses.
    Liu ZP; Luo JW; Xu GZ; Gao L; Yi JL; Huang XD; Qu Y; Wang K; Zhang SP; Xiao JP
    Acta Otolaryngol; 2017 Oct; 137(10):1115-1120. PubMed ID: 28767022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective randomized comparison of dacarbazine (DTIC) versus DTIC plus interferon-alpha (IFN-alpha) in metastatic melanoma.
    Young AM; Marsden J; Goodman A; Burton A; Dunn JA
    Clin Oncol (R Coll Radiol); 2001; 13(6):458-65. PubMed ID: 11824887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of paclitaxel and carboplatin as second-line therapy for patients with metastatic melanoma.
    Rao RD; Holtan SG; Ingle JN; Croghan GA; Kottschade LA; Creagan ET; Kaur JS; Pitot HC; Markovic SN
    Cancer; 2006 Jan; 106(2):375-82. PubMed ID: 16342250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.